David Hill, MD
Otolaryngology · Olathe, KSNPI 1891756862
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,039 of the $5,033 with a category attached, or 60.4%. 20 manufacturers reported payments, led by Intersect ENT, Inc. at 52.9% of the total. Reporting peaked in 2019 at $2,703 and has fallen 95.4% since, to $123 in 2025.
Across 75 payments — averaging $67.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$3K
- Medical Device Business Services, Inc.$1K
- Aerin Medical Inc.$534
- Sanofi$169
- Optinose US, Inc.$108
- AbbVie$86
- plus $373 from 14 others
What the payments were for
- Travel & lodging$3,03960%
- Food & beverage$1,99040%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 8 | $2,662 |
| Medical Device Business Services, Inc. | 7 | $1,101 |
| Aerin Medical Inc. | 24 | $534 |
| Sanofi | 7 | $169 |
| Optinose US, Inc. | 5 | $108 |
| AbbVie | 5 | $86 |
| Smith+Nephew | 3 | $76 |
| Inspire Medical Systems, Inc. | 2 | $48 |
| Acclarent, Inc | 2 | $45 |
| Covidien LP | 2 | $37 |
| Merck | 1 | $22 |
| Alk-abello, Inc | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $19 |
| GSK | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Aytu Biopharma, Inc. | 1 | $13 |
| Stryker | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SINUVA$2,564
How this compares
$5,033 in reported general payments places this provider in the 80th percentile of 87 otolaryngology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 152 | $3,422 |
| Azelastine Hcl | 104 | $2,351 |
| Prednisolone Acetate | 29 | $786 |
| CefuroximeCefuroxime Axetil | 36 | $421 |
| Ofloxacin | 25 | $413 |
| Montelukast Sodium | 52 | $367 |
| Fluticasone Propionate | 11 | $327 |
| Methylprednisolone | 41 | $302 |
| Doxycycline Hyclate | 17 | $200 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $112 |
| Famotidine | 14 | $78 |
| Prednisone | 40 | $65 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Olathe
- Brian MetzOlathe$2K
- Bruce ZimmermanOlathe$758
- Hinrich StaeckerKansas City$499K
- Stanley McClurgMerriam$133K
- Douglas CowanLeawood$32K
- Jennifer VillwockKansas City$26K
- David RudmanOverland Park$18K
- Nicholas WirtzMerriam$14K
- Meha FoxKansas City$12K
- Kiran KakaralaKansas City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.